查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1390555

2023-2028 年脊椎生物製劑市場報告（按產品、手術類型、最終用戶和地區分類）

Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球脊椎生物製劑市場規模達到20億美元。展望未來， IMARC Group預計到2028年市場規模將達到25億美元，2022-2028年複合年成長率（CAGR）為3.79%。

脊椎生物製品是透過活躍的細胞過程改變周圍環境的材料。它們促進生長和分化，並有助於損傷的修復和癒合。它們還減少了主要或額外外科手術的頻率，並減少了軟組織的損害。目前，多種脊椎生物製劑被用作傳統治療的替代品。例如，椎弓根螺釘和桿在脊椎融合手術中得到應用，以提供脊椎穩定，從而促進癒合。此外，不斷的進步正在促進軟骨和骨結構的修復和再生。

脊椎生物製劑市場趨勢：

脊椎融合術被用作治療脊椎創傷、腫瘤和退化性疾病的工具。然而，其不良結果可能會導致患者出現嚴重的併發症。這與患有急性和慢性疾病的人數顯著增加相結合，成為積極影響全世界脊椎生物製劑使用的關鍵因素之一。脊椎生物製劑會影響細胞層面的融合，這有助於在治療症狀性畸形或不穩定時成功實現關節固定術。此外，全球老年人口數量增加，他們更容易受到肌肉骨骼疾病的影響。這加上骨科疾病的日益流行，正在刺激全球對脊椎生物製劑的需求。除此之外，對非手術程序不斷成長的需求正在鼓勵脊椎生物製劑在微創腰椎手術中的使用。脊椎生物製劑作為金屬硬體的替代品以及個別天然骨移植物或異體移植物也越來越受到關注。此外，由於收入水準的提高，獲得醫療服務的機會不斷增加也促進了市場的成長。

本報告回答的關鍵問題

  • 全球脊椎生物製劑市場有多大？
  • 2023-2028年全球脊椎生物製品市場的預期成長率是多少？
  • 推動全球脊椎生物製品市場的關鍵因素是什麼？
  • COVID-19 對全球脊椎生物製劑市場有何影響？
  • 基於該產品的全球脊椎生物製品市場的詳細情形如何？
  • 根據手術類型，全球脊椎生物製品市場的詳細情形如何？
  • 基於最終用戶的全球脊椎生物製品市場的詳細情形如何？
  • 全球脊椎生物製劑市場的關鍵區域有哪些？
  • 全球脊椎生物製劑市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球脊椎生物製品市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 同種異體脊椎移植物
    • 市場走向
    • 關鍵環節
      • 機械加工骨同種異體移植物
      • 去礦骨基質
    • 市場預測
  • 骨移植替代品
    • 市場走向
    • 關鍵環節
      • 骨形態發生蛋白
      • 合成骨移植物
    • 市場預測
  • 基於細胞的矩陣
    • 市場走向
    • 市場預測

第 7 章：依手術類型分類的市場細分

  • 開放式脊椎手術
    • 市場走向
    • 市場預測
  • 微創脊椎手術
    • 市場走向
    • 市場預測

第 8 章：最終用戶的市場區隔

  • 醫院
    • 市場走向
    • 市場預測
  • 門診護理中心
    • 市場走向
    • 市場預測
  • 脊椎手術中心
    • 市場走向
    • 市場預測
  • 骨科診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Arthrex Inc
    • Alphatec Holdings Inc.
    • Exactech Inc
    • Johnson & Johnson
    • Medtronic plc
    • NuVasive Inc
    • Orthofix Medical Inc.
    • Stryker Corporation
    • Wright Medical Group NV
    • Zimmer Biomet
Product Code: SR112023A4333

Abstract

The global spine biologics market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 3.79% during 2022-2028.

Spine biologics are materials that alter the surrounding environment through active cellular processes. They promote growth and differentiation and aid in the repair and healing of an injury. They also reduce the frequency of primary or additional surgical procedures and decrease the disruption of soft tissue. At present, a wide variety of spine biologics are used as an alternative to conventional treatments. For instance, pedicle screws and rods find application in a spine fusion procedure to provide spinal stabilization, thereby promoting healing. Moreover, continuous advancements are promoting the repair and regeneration of cartilaginous and bony structures.

Spine Biologics Market Trends:

Spine fusion is utilized as a tool in the treatment of spine trauma, tumors, and degenerative disorders. However, its poor outcomes can lead to serious complications among patients. This, in confluence with a significant increase in the number of individuals with acute and chronic conditions represents one of the key factors positively influencing the use of spine biologics around the world. Spine biologics impact fusion at the cellular level, which helps achieve successful arthrodesis in the treatment of symptomatic deformity or instability. Moreover, there is a rise in the geriatric population globally, which is more susceptible to musculoskeletal conditions. This, along with the growing prevalence of orthopedic conditions, is catalyzing the demand for spine biologics worldwide. Apart from this, the escalating demand for non-surgical procedures is encouraging the use of spinal biologics in minimally invasive lumbar surgeries. Spine biologics are also gaining traction as a replacement for metal hardware and in individual natural bone grafts or allografts. Furthermore, the growing access to healthcare services on account of inflating income levels is contributing to market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global spine biologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, surgery type and end user.

Breakup by Product:

Spinal Allografts

Machined Bones Allograft

Demineralized Bone Matrix

Bone Graft Substitutes

Bone Morphogenetic Proteins

Synthetic Bone Grafts

Cell Based Matrix

Breakup by Surgery Type:

Open Spine Surgery

Minimally Invasive Spine Surgery

Breakup by End User:

Hospitals

Ambulatory Care Centers

Spinal Surgery Centers

Orthopedic Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc, Alphatec Holdings Inc., Exactech Inc, Johnson & Johnson, Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.

Key Questions Answered in This Report

  • 1. How big is the global spine biologics market?
  • 2. What is the expected growth rate of the global spine biologics market during 2023-2028?
  • 3. What are the key factors driving the global spine biologics market?
  • 4. What has been the impact of COVID-19 on the global spine biologics market?
  • 5. What is the breakup of the global spine biologics market based on the product?
  • 6. What is the breakup of the global spine biologics market based on the surgery type?
  • 7. What is the breakup of the global spine biologics market based on the end user?
  • 8. What are the key regions in the global spine biologics market?
  • 9. Who are the key players/companies in the global spine biologics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Spine Biologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Spinal Allografts
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Machined Bones Allograft
      • 6.1.2.2 Demineralized Bone Matrix
    • 6.1.3 Market Forecast
  • 6.2 Bone Graft Substitutes
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bone Morphogenetic Proteins
      • 6.2.2.2 Synthetic Bone Grafts
    • 6.2.3 Market Forecast
  • 6.3 Cell Based Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Surgery Type

  • 7.1 Open Spine Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Minimally Invasive Spine Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Spinal Surgery Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Orthopedic Clinics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Arthrex Inc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Alphatec Holdings Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Exactech Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Medtronic plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 NuVasive Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Orthofix Medical Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Stryker Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Wright Medical Group N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Zimmer Biomet
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Spine Biologics Market: Major Drivers and Challenges
  • Figure 2: Global: Spine Biologics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Spine Biologics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Spine Biologics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Spine Biologics Market: Breakup by Surgery Type (in %), 2022
  • Figure 6: Global: Spine Biologics Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Spine Biologics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Spine Biologics (Spinal Allografts) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Spine Biologics (Spinal Allografts) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Spine Biologics (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Spine Biologics (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Spine Biologics (Cell Based Matrix) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Spine Biologics (Cell Based Matrix) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Spine Biologics (Open Spine Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Spine Biologics (Open Spine Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Spine Biologics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Spine Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Spine Biologics (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Spine Biologics (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Spine Biologics (Spinal Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Spine Biologics (Spinal Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Spine Biologics (Orthopedic Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Spine Biologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Spine Biologics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Spine Biologics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Spine Biologics Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Spine Biologics Industry: SWOT Analysis
  • Figure 78: Global: Spine Biologics Industry: Value Chain Analysis
  • Figure 79: Global: Spine Biologics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Spine Biologics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Spine Biologics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Spine Biologics Market Forecast: Breakup by Surgery Type (in Million US$), 2023-2028
  • Table 4: Global: Spine Biologics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Spine Biologics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Spine Biologics Market: Competitive Structure
  • Table 7: Global: Spine Biologics Market: Key Players